Breadcrumb

What's New at the RI-MUHC ?

Medical writing: caution warranted if using ChatGPT

Researchers from CHU Sainte-Justine and the Montreal Children's Hospital recently asked ChatGPT 20 medical questions...

New understanding of processes involved in breast cancer metastasis

A study led by RI-MUHC researcher Nathalie Lamarche-Vane reveals the mechanisms underlying regulation...

Unravelling mechanisms for cardiovascular therapeutics

RI-MUHC researchers co-lead a team that combines novel pharmacology with structural biology and computational modelling to discover new domains...

All airway trees are not created equal

An RI-MUHC study suggests that lung development in early life has an impact on the risk of premature death

World-first clinical trial to help millions of people with penicillin allergies

The PALACE study, an international research endeavour, has evaluated a safer and simpler approach to penicillin allergy testing

New research aims to make prostate cancer prognostics more precise

A team of RI-MUHC researchers is developing DNA biomarkers to better pinpoint treatment options for patients with prostate cancer

Leading the way towards improved treatment for atrial fibrillation

Always on the lookout for major developments in electrophysiology, MUHC clinical teams work closely with research teams at the RI-MUHC to offer the most innovative treatments to patients

New advances in lung cancer treatment

Results of an international clinical trial confirm the efficiency of an immunotherapy treatment for early stage non-small cell lung cancer

A new research study may reduce surgical interventions for baby girls

Work by a team of child health researchers from the RI-MUHC and across Canada provides new insights into treatment for fetal ovarian cysts

How do we define death? Canada now has clear clinical guidelines

Brain-based definition of death becomes the central concept of the new Canadian guidelines

Learn more about the RI-MUHC